 |
|
 |
|
|
|
NEWS RELEASE:
FOR IMMEDIATE RELEASE:
|
|
|
MERGE HEALTHCARE TELERADIOLOGY DIVISION RECEIVES ACCREDITATION
FROM JOINT COMMISSION
Milwaukee, WI, November 27, 2007 – Merge Healthcare (NASDAQ: MRGE; TSX: MRG), a leading medical imaging software and services provider, announced today that its Merge Healthcare Teleradiology division has been awarded the Joint Commission’s Gold Seal of Approval™, by demonstrating compliance with the Joint Commission on Accreditation of Healthcare Organization’s national standard for healthcare quality and safety. On November 20, 2007, Merge Healthcare announced the introduction of a new teleradiology application called Merge TeleRead and a new teleradiology service, Consult PreReads™, a premium image pre-reading service of its newly formed Merge Healthcare Teleradiology division. Consult PreReads are provided by skilled remotely-based radiologists.
"We have established our systems and processes to support the Joint Commission’s strict licensing and credentialing verification, especially in regard to healthcare quality and patient safety," said Kenneth Rardin, Merge Healthcare CEO. "We go beyond those standards with other types of verifications and references to ensure the highest level of Consult PreReads."
"Achieving accreditation demonstrates that Merge Healthcare voluntarily sought an independent evaluation of its compliance with state-of-the-art performance standards," says Michael Kulczycki, executive director, Ambulatory Care Accreditation Program, The Joint Commission.
Founded in 1951, the Joint Commission on Accreditation of Healthcare Organizations seeks to continuously improve the safety and quality of care provided to the public through the provision of healthcare accreditation and related services that support performance improvement in healthcare organizations. The Joint Commission evaluates and accredits more than 15,000 healthcare organizations and programs in the United States, including more than 7,800 hospitals and home care organizations and more than 7,300 other healthcare organizations that provide long-term care, assisted living, behavioral healthcare, laboratory, and ambulatory care services. An independent, not-for-profit organization, the Joint Commission is the nation's oldest and largest standards-setting and accrediting body in healthcare.
# # #
Merge Healthcare is a market leader in the development and delivery of medical imaging and information management software and services. Our innovative software solutions use leading-edge imaging software technologies that accelerate market delivery for our OEM customers, while our end-user solutions improve our customers' productivity and enhance the quality of patient care they provide. For additional information, visit our website at www.mergehealthcare.com.
All trademarks appearing in this release are the property of Cedara Software Corp. and/or Merge Healthcare.
|
Attn: Beth Frost-Johnson
Merge Healthcare
6737 West Washington St.
Suite 2250
Milwaukee, WI 53214
|
|
 |
|
 |
|
| Except for the historical information herein, the matters discussed in this news release include forward-looking statements that may involve a number of risks and uncertainties. When used in this press release, the words “will,” “believes,” “intends,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Actual results could differ materially from those expressed in, or implied by, the forward-looking statements based on a number of factors, including, but not limited to, the uncertainty created by, the adverse impact on relationships with customers, potential customers, suppliers and investors potentially resulting from, and other risks associated with, the changes in the Company’s senior management; costs, risks and effects of the investigation by the Audit Committee of the Board of Directors; the impact of the restatement of financial statements of the Company and other actions that may be taken or required as a result of such restatement; the Company's inability to timely file reports with the Securities and Exchange Commission; risks associated with the Company's inability to meet the requirements of The NASDAQ Stock Market for continued listing, including possible delisting; costs, risks and effects of legal proceedings and investigations, including the informal, non-public inquiry being conducted by the Securities and Exchange Commission and class action, derivative, and other lawsuits; risks in product and technology development, market acceptance of new products and continuing product demand, the impact of competitive products and pricing, ability to integrate acquisitions, changing economic conditions, credit and payment risks associated with end-user sales, dependence on major customers, dependence on key personnel, and other risk factors detailed in the Company’s filings with the Securities and Exchange Commission. Except as expressly required by the federal securities laws, the Company undertakes no obligation to update such factors or to publicly announce the results of any of the forward-looking statements contained herein to reflect future events, developments, or changed circumstances, or for any other reason.
|
|
|